Smart insulin pump could help pregnant women with diabetes
NCT ID NCT07602036
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test an automated insulin delivery system (the Medtronic 780G pump with continuous glucose monitoring) in 20 pregnant women with type 2 diabetes. Participants join before 16 weeks of pregnancy and use the device until delivery. The main goal is to see how much time their blood sugar stays in a safe range (63-140 mg/dL). Researchers will also track overall glucose control and health outcomes for mothers and newborns.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Medtronic 780G automated insulin delivery system
What this could lead to
If successful, this could show that automated insulin pumps help pregnant women with type 2 diabetes maintain safer blood sugar levels, potentially improving health for both mother and baby.
What could go wrong
This is a small, early-stage study with only 20 participants and no comparison group, so results may not apply widely. The device may not perform as well in pregnancy as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heliodor Swiecicki Clinical Gynecology and Obstetrics Hospital of Poznan University of Medical Sciences
Poznan, Wielkopolska, 60-535, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact